Russell Investments Group, Ltd. Neuronetics, Inc. Transaction History

Russell Investments Group, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$6.22 - $15.54 $1.28 Million - $3.2 Million	-206,090 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$10.15 - $17.25 $1.07 Million - $1.82 Million	-105,352 Reduced 33.83%	206,090 $3.3 Million
Q1 2021 May 10, 2021	BUY	$10.6 - $21.27 $2.09 Million - $4.19 Million	197,059 Added 172.28%	311,442 $3.85 Million
Q4 2020 Feb 08, 2021	BUY	$4.95 - $11.45 $503,934 - $1.17 Million	101,805 Added 809.39%	114,383 $1.27 Million
Q3 2020 Nov 09, 2020	SELL	$1.82 - $5.87 $40,833 - $131,699	-22,436 Reduced 64.08%	12,578 $61,000
Q4 2019 Jan 29, 2020	BUY	$4.03 - $9.22 $141,106 - $322,829	35,014 New	35,014 $156,000
Q4 2018 Feb 11, 2019	SELL	$16.0 - $31.84 $192,896 - $383,863	-12,056 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$24.32 - $37.54 $13,351 - $20,609	-549 Reduced 4.36%	12,056 $387,000
Q2 2018 Aug 08, 2018	BUY	$26.61 - $27.78 $335,419 - $350,166	12,605 New	12,605 $335,000

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $65.9M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.